Basit öğe kaydını göster

dc.contributor.authorOztaner, Serdar Murat
dc.contributor.authorTemizel, Tugba Taskaya
dc.contributor.authorErdem, S. Remzi
dc.contributor.authorOzer, Mahmut
dc.date.accessioned2023-12-28T10:23:50Z
dc.date.available2023-12-28T10:23:50Z
dc.date.issued2015
dc.identifier.issn2168-2194en_US
dc.identifier.urihttp://hdl.handle.net/11727/11239
dc.description.abstractThe incorporation of pharmacogenomics information into the drug dosing estimation formulations has been shown to increase the accuracy in drug dosing and decrease the frequency of adverse drug effects in many studies in the literature. In this paper, an estimation framework based on the Bayesian structural equation modeling, which is driven by pharmacogenomics, is proposed. The results show that the model compares favorably with the linear models in terms of prediction and explaining the variations in warfarin dosing.en_US
dc.language.isoengen_US
dc.relation.isversionof10.1109/JBHI.2014.2336974en_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectBayesian structural equation modelingen_US
dc.subjectdata miningen_US
dc.subjectpersonalized medicineen_US
dc.subjectpharmacogenomicsen_US
dc.titleA Bayesian Estimation Framework for Pharmacogenomics Driven Warfarin Dosing: A Comparative Studyen_US
dc.typearticleen_US
dc.relation.journalIEEE JOURNAL OF BIOMEDICAL AND HEALTH INFORMATICSen_US
dc.identifier.volume19en_US
dc.identifier.issue5en_US
dc.identifier.startpage1724en_US
dc.identifier.endpage1733en_US
dc.identifier.wos000360791200022en_US
dc.identifier.scopus2-s2.0-84941010543en_US
dc.identifier.eissn2168-2208en_US
dc.contributor.pubmedID25020183en_US
dc.contributor.orcID0000-0002-7537-2170en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.contributor.researcherIDAAJ-2370-2021en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster